Slowing Tecfidera Sales Increases Biogen's (BIIB) M&A Risk - Moody's
Go back to Slowing Tecfidera Sales Increases Biogen's (BIIB) M&A Risk - Moody's| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 220.84 -3.67 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $224.51 | 52 Week High | $333.65 | |||
| Open | $221.15 | 52 Week Low | $223.02 | |||
| Day High | $223.82 | P/E | 28.28 | |||
| Day Low | $219.82 | EPS | $7.81 | |||
| Volume | 134,326 | |||||

